Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening.

Vaivade A, Erngren I, Carlsson H, Freyhult E, Emami Khoonsari P, Noui Y, Al-Grety A, Åkerfeldt T, Spjuth O, Gallo V, Larsson AO, Kockum I, Hedström AK, Alfredsson L, Olsson T, Burman J, Kultima K

Nat Commun 16 (1) 2014 [2025-02-27; online 2025-02-27]

Exposure to per- and polyfluorinated substances (PFAS) and hydroxylated polychlorinated biphenyls (OH-PCBs) is associated with adverse human health effects, including immunosuppression. It is unknown if these substances can affect the course of autoimmune diseases. This study was based on 907 individuals with multiple sclerosis (MS) and 907 matched controls, where the MS cases were followed longitudinally using the Swedish MS register. We demonstrate sex- and disease-specific differences in serum PFAS concentrations between individuals with MS and controls. Moreover, two OH-PCBs (4-OH-CB187 and 3-OH-CB153) are associated with an increased risk of developing multiple sclerosis, regardless of sex and immigration status. With a clinical follow-up time of up to 18 years, an increase in serum concentrations of perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorodecanoic acid (PFDA) decreases the risk of confirmed disability worsening in both sexes, as well as perfluoroheptanesulfonic acid (PFHpS) and perfluorononanoic acid (PFNA), only in males with MS. These results show previously unknown associations between OH-PCBs and the risk of developing MS, as well as the inverse associations between PFAS exposure and the risk of disability worsening in MS.

Bioinformatics (NBIS) [['Collaborative', 'Collaborative']]

Bioinformatics Long-term Support WABI [Collaborative]

Bioinformatics Support, Infrastructure and Training [Collaborative]

PubMed 40016224

DOI 10.1038/s41467-025-57172-3

Crossref 10.1038/s41467-025-57172-3

pii: 10.1038/s41467-025-57172-3